OncoMed Pharmaceuticals, Inc.  
     
 
 
 

Our Mission

OncoMed Pharmaceuticals is a development-stage biotechnology company dedicated to improving cancer treatment by discovering and developing monoclonal antibodies and other agents that target the biologic pathways critical to tumor initiating cells, also known as "cancer stem cells". We are leveraging our understanding of these tumor initiating cells to discover and develop novel therapeutics that could provide important alternatives for the treatment of cancer.

R&D Day

April 29, 2015 in NYC OncoMed 2015 Research & Development Day
  Press Release Archives 
 

Latest Presentations

April 2015 European Lung Cancer Conference January 2015 2015 Gastrointestinal Cancer Symposium